Revenue - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Dec. 04, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation Of Revenue [Line Items]
Revenue from contract with customer, excluding assessed tax		$ (53)	$ 354	$ 800	$ 1,397
Royalty receivable, current portion		2,705		2,705
Mayne Pharma Agreement [Member]
Disaggregation Of Revenue [Line Items]
Revenue from contract with customer, excluding assessed tax		100
Royalty receivable, current portion		$ 300		$ 300
Mayne License Agreement [Member]
Disaggregation Of Revenue [Line Items]
Period of royalty payments	20 years
Decrease in royalty rate on product-by-product basis	2.00%
Minimal annual royalty payment	$ 3,000
Period of minimal annual royalty payment	12 years
Inflation rate adjusted for minimal annual royalty payment	3.00%
Mayne License Agreement [Member] \| If Aggregate Net Sales Reach $100.0 Million [Member]
Disaggregation Of Revenue [Line Items]
One-time milestone payments	$ 5,000
Threshold net sales amount to determine one-time milestone payment	100,000
Mayne License Agreement [Member] \| If Aggregate Net Sales Reach $200.0 Million [Member]
Disaggregation Of Revenue [Line Items]
One-time milestone payments	10,000
Threshold net sales amount to determine one-time milestone payment	200,000
Mayne License Agreement [Member] \| If Aggregate Net Sales Reach $300.0 Million [Member]
Disaggregation Of Revenue [Line Items]
One-time milestone payments	15,000
Threshold net sales amount to determine one-time milestone payment	$ 300,000
Mayne License Agreement [Member] \| First $80 Million in Annual Net Sales [Member]
Disaggregation Of Revenue [Line Items]
Royalty rate as percentage on net sales	8.00%
Threshold annual net sales to determine royalty rate	$ 80,000
Mayne License Agreement [Member] \| Above $80 Million in Annual Net Sales [Member]
Disaggregation Of Revenue [Line Items]
Royalty rate as percentage on net sales	7.50%
Threshold annual net sales to determine royalty rate	$ 80,000